MX9102627A - Composicion farmaceutica de dobutamina para administracion transdermica. - Google Patents

Composicion farmaceutica de dobutamina para administracion transdermica.

Info

Publication number
MX9102627A
MX9102627A MX9102627A MX9102627A MX9102627A MX 9102627 A MX9102627 A MX 9102627A MX 9102627 A MX9102627 A MX 9102627A MX 9102627 A MX9102627 A MX 9102627A MX 9102627 A MX9102627 A MX 9102627A
Authority
MX
Mexico
Prior art keywords
dobutamine
pharmaceutical composition
transdermic administration
transdermic
administration
Prior art date
Application number
MX9102627A
Other languages
English (en)
Inventor
Kirti Himatlal Valia
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX9102627A publication Critical patent/MX9102627A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
MX9102627A 1990-12-20 1991-12-17 Composicion farmaceutica de dobutamina para administracion transdermica. MX9102627A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63048090A 1990-12-20 1990-12-20

Publications (1)

Publication Number Publication Date
MX9102627A true MX9102627A (es) 1992-06-01

Family

ID=24527346

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9102627A MX9102627A (es) 1990-12-20 1991-12-17 Composicion farmaceutica de dobutamina para administracion transdermica.

Country Status (12)

Country Link
EP (1) EP0492930A3 (es)
JP (1) JPH04275219A (es)
KR (1) KR920011479A (es)
AU (1) AU8985791A (es)
BR (1) BR9105371A (es)
CA (1) CA2057647A1 (es)
CS (1) CS379491A3 (es)
HU (1) HU914012D0 (es)
IE (1) IE914453A1 (es)
IL (1) IL100367A0 (es)
MX (1) MX9102627A (es)
ZA (1) ZA919853B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2688288T3 (es) * 2011-02-15 2018-10-31 Elanco Us Inc. Procedimientos para controlar el dolor en caninos utilizando una solución transdérmica de fentanilo

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3527864A (en) * 1966-11-18 1970-09-08 Procter & Gamble Compositions for topical application to animal tissue and method of enhancing penetration thereof
US3551554A (en) * 1968-08-16 1970-12-29 Crown Zellerbach Corp Enhancing tissue penetration of physiologically active agents with dmso
US3987200A (en) * 1972-04-12 1976-10-19 Eli Lilly And Company Method for increasing cardiac contractility
US4581225A (en) * 1984-04-25 1986-04-08 Eli Lilly And Company Sustained release intranasal formulation and method of use thereof
US4704407A (en) * 1984-12-20 1987-11-03 Eli Lilly And Company Soluble dobutamine salts
CA1272445A (en) * 1985-02-25 1990-08-07 Yie W. Chien Transdermal pharmaceutical absorption dosage unit and process of pharmaceutical administration
JPS62169723A (ja) * 1986-01-22 1987-07-25 Teisan Seiyaku Kk 徐放化製剤
US4814173A (en) * 1987-09-08 1989-03-21 Warner-Lambert Company Silicone elastomer transdermal matrix system

Also Published As

Publication number Publication date
AU8985791A (en) 1992-06-25
CA2057647A1 (en) 1992-06-21
KR920011479A (ko) 1992-07-24
IE914453A1 (en) 1992-07-01
ZA919853B (en) 1993-06-14
BR9105371A (pt) 1992-08-25
CS379491A3 (en) 1992-07-15
IL100367A0 (en) 1992-09-06
HU914012D0 (en) 1992-03-30
EP0492930A2 (en) 1992-07-01
EP0492930A3 (en) 1992-10-14
JPH04275219A (ja) 1992-09-30

Similar Documents

Publication Publication Date Title
MX9101175A (es) Composicion farmaceutica para administracion nasal
FI901102A0 (fi) Farmaceutiska kompositioner.
FI922364A0 (fi) Farmaceutiska kompositioner.
DE3586545T2 (de) Erhoehte schmerzlosigkeit bewirkende pharmazeutische zusammensetzungen.
MX9204354A (es) Compuestos heterociclicos de 5 miembros, procedimiento para prepararlos y composiciones farmaceuticas que los contienen.
DE69101931T2 (de) Pharmazeutische Zusammensetzung.
DE3863963D1 (de) Pharmazeutische zusammensetzungen.
FR2636532B1 (fr) Compositions pharmaceutiques
DE69115263D1 (de) Pharmazeutische zusammensetzungen.
MX9100465A (es) Complejos de ciclodextrina para administracion neuroaxial de medicamentos
DE3868986D1 (de) Pharmazeutische zusammensetzungen.
IT8920486A0 (it) Composizioni farmaceutiche.
FI925778A0 (fi) Farmaceutiskt aktiva bensokinazolinfoereningar
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
MX9102701A (es) Derivados de 2-acilamido de 3,4-dihidro-3-oxo-quinoxalina que tienen actividad farmaceutica.
DZ1559A1 (fr) Compositions pharmaceutiques.
IT1290797B1 (it) Composizioni farmaceutiche stabilizzate
MC1878A1 (fr) Compositions pharmaceutiques
FI923371A (fi) En farmaceutisk formulation.
MX9203732A (es) R-enentiomeros de compuestos de n-propargil-1-aminoindan, su preparacion y composiciones farmaceuticas que contienen los mismos.
NO306381B1 (no) Farmasöytisk ampulle
MX9102627A (es) Composicion farmaceutica de dobutamina para administracion transdermica.
DE3866789D1 (de) Pharmazeutische zusammensetzungen.
IT7822316A0 (it) Composizione farmaceutica per la somministrazione di pancreatina.
DE3768109D1 (de) Pharmazeutische zusammensetzungen.